EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Brain-Derived Neurotrophic Factor (BDNF) as a Predictor of Treatment Response in Major Depressive Disorder (MDD): A Systematic Review

Mario Ignacio Zelada, Verónica Garrido, Andrés Liberona, Natalia Jones, Karen Zúñiga, Hernán Silva, Rodrigo R Nieto iD

International Journal of Molecular Sciences · 30.09.2023 · 24 (19) · 14810

DOI: 10.3390/ijms241914810 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.09.2023. Verfasst von Mario Ignacio Zelada und 6 weiteren Autor:innen. Beteiligte Einrichtung: Escuela de Medicina, Facultad de Medicina, Universidad de Chile, Santiago 8380453, Chile. Hauptthemen laut MEDLINE: Major Depressive Disorder, Depressive Disorder, Treatment-Resistant. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondecyt de Iniciación 2023, Agencia Nacional de Investigación y Desarrollo (ANID).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Brain-derived neurotrophic factor (BDNF) has been studied as a biomarker of major depressive disorder (MDD). Besides diagnostic biomarkers, clinically useful biomarkers can inform response to treatment. We aimed to review all studies that sought to relate BDNF baseline levels, or BDNF polymorphisms, with response to treatment in MDD. In order to achieve this, we performed a systematic review of studies that explored the relation of BDNF with both pharmacological and non-pharmacological treatment. Finally, we reviewed the evidence that relates peripheral levels of BDNF and BDNF polymorphisms with the development and management of treatment-resistant depression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderDepressive Disorder, Treatment-ResistantHumansBrain-Derived Neurotrophic FactorBiomarkersPolymorphism, Genetic

Stichwörter der Autor:innen

BDNFbiomarkersmajor depressionmajor depressive disorderneurotrophinstreatment refractorinesstreatment resistancetreatment responsetreatment-resistant depression

Substanzen

Brain-Derived Neurotrophic FactorBiomarkers

Autor:innen und Institutionen

  • Escuela de Medicina, Facultad de Medicina, Universidad de Chile, Santiago 8380453, Chile.
  • Clínica Psiquiátrica Universitaria, Hospital Clínico de la Universidad de Chile, Universidad de Chile, Santiago 8380453, Chile.
  • Departamento de Psiquiatría y Salud Mental Norte, Facultad de Medicina, Universidad de Chile, Santiago 8380453, Chile.
  • Departamento de Neurociencias, Facultad de Medicina, Universidad de Chile, Santiago 8380453, Chile.

ORCID-Profile: Rodrigo R Nieto

Förderung

  • Fondecyt de Iniciación 2023
  • Agencia Nacional de Investigación y Desarrollo (ANID)

Zitieren

APA

Zelada, M. I., Garrido, V., Liberona, A., Jones, N., Zúñiga, K., Silva, H., & Nieto, R. R. (2023). Brain-Derived Neurotrophic Factor (BDNF) as a Predictor of Treatment Response in Major Depressive Disorder (MDD): A Systematic Review. International Journal of Molecular Sciences, 24(19), 14810. https://doi.org/10.3390/ijms241914810

Vancouver

Zelada MI, Garrido V, Liberona A, Jones N, Zúñiga K, Silva H, et al. Brain-Derived Neurotrophic Factor (BDNF) as a Predictor of Treatment Response in Major Depressive Disorder (MDD): A Systematic Review. International Journal of Molecular Sciences. 2023;24(19):14810. doi:10.3390/ijms241914810

BibTeX
@article{Zelada2023,
  author = {Zelada, Mario Ignacio and Garrido, Verónica and Liberona, Andrés and Jones, Natalia and Zúñiga, Karen and Silva, Hernán and Nieto, Rodrigo R},
  title = {Brain-Derived Neurotrophic Factor (BDNF) as a Predictor of Treatment Response in Major Depressive Disorder (MDD): A Systematic Review},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {19},
  pages = {14810},
  doi = {10.3390/ijms241914810}
}
Kostenlos starten →